Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer

Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway blockade is a promising new cancer therapy. Although PD-1/PD-L1 treatment has yielded clinical benefits in several types of cancer, further studies are required to clarify predictive biomarkers for drug efficacy and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Mol Med
Autors principals: Kim, Dong Ha, Kim, HyeongRyul, Choi, Yun Jung, Kim, Seon Ye, Lee, Jung-Eun, Sung, Ki Jung, Sung, Young Hoon, Pack, Chan-Gi, Jung, Min-kyo, Han, Buhm, Kim, Kunhee, Kim, Woo Sung, Nam, Soo Jeong, Choi, Chang-Min, Yun, Miyong, Lee, Jae Cheol, Rho, Jin Kyung
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802663/
https://ncbi.nlm.nih.gov/pubmed/31399559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-019-0295-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars